• <tbody id="nqipc"></tbody>
        <tbody id="nqipc"></tbody>

        <tbody id="nqipc"></tbody>
        <tbody id="nqipc"></tbody>
           

          上海三維生物技術有限公司

           
          展示
           
           
           
           

          SunGran—Significant scientific-research achievement of national “863” plan on biological high-tech

          SunGran Injection is a new and high-tech product on gene engineering, which is researched by Academy of Military Medical Sciences and is manufactured by Shanghai Sunway Biotech Co., Ltd. It is a recombinant human granulocyte-colony stimulating factor which is used recombinant DNA technology. SunGran has the same biological activity with natural human granulocyte -colony stimulating factor. The product is granted a significant scientific-research achievement of national high-tech research “863” plan on biological high-tech.

          SunGran—national significant new product

          SunGran was approved as national significant new product and got a certificate by five national ministries and commissions in 2002.

          SunGran—Introduction of export

          SunGran was begun export on December, 2004. It is selled in India and Pakistan at present.

           
           
           
           
           

          SunGran—First choice on increasing leukocyte drugs

          rhG-CSF is a new high-tech product on biological engineering. It was approved by FDA (the United State) in 1991. rhG-CSF can increase leukocyte rapidly. Its curative effect is significant and side effect is slight. rhG-CSF is the first choice on treating the lack of leukocyte in clinical at present.

          Some hematopoietic cytokines, such as G-CSF, which have single effect in development process of myeloid stem cells and act on late phase of hematopoietic stem cell differentiation, have a significant curative effect and slight side effects in clinical. While others, which have general effects or early phase, have a bigger side effect in clinical.

          The market share of G-CSF is much larger than other hematopoietic cytokines in current domestic and foreign markets. Besides, It has a good market in gene engineering products.

           
           
           
           
           

          溝通合作

          • 營銷中心:上海市浦東新區商城路518號內外聯大廈2105室
          • 郵編:200120
          • 傳真:021-58783831
          • 電話:021-63523313
          • e-mail:xiaoshoubu@sunwaybio.com.cn
           
           
           
           
           
          總部地址:上海市浦東新區金橋出口加工區桂橋路1150號C座    郵編:201206    傳真:021-58999488    電話:021-50310270    e-mail:sunwaybio@sunwaybio.com.cn
          影视先锋男人站_99久久中文字幕伊人情人_2020年最新国产精品_动漫精品欧美一区二区三区

        1. <tbody id="nqipc"></tbody>
              <tbody id="nqipc"></tbody>

              <tbody id="nqipc"></tbody>
              <tbody id="nqipc"></tbody>